For the first time we are offering the datapacks behind our R&D Intelligence whitepapers. To start we are offering three datapacks to the whitepapers: '2016 Clinical Trials Roundup: Steady course or changing tides?', 'Pharmaprojects Pharma R&D Annual Review 2016' and 'Pharma R&D Annual Review 2016 Supplement: New Active Substances launched during 2015'.

Datapack – 2016 Clinical Trials Roundup: Steady course or changing tides?
Get an in-depth overview of clinical trials that initiated in 2015 and perform your own in-depth analysis. This datapack presents the supporting data from our landmark white paper, 2016 Clinical Trials Roundup: Steady course or changing tides? Sourced from Trialtrove, the industry’s gold standard for clinical trials intelligence, the data covers clinical trials of unapproved drugs that initiated in 2015 to elucidate any ongoing, or new, trends within the world of pharma R&D, focusing on the six major therapeutic areas (TAs) of autoimmune/inflammation, cardiovascular, CNS, infectious disease, metabolic/endocrinology, and oncology. Included with your purchase, our white paper provides insight into how the course of pharma R&D has fared, with metrics by TA, trial phase, disease, and sponsor, while the datapack allows you to perform your own analysis and dive deeper into the underlying data.